{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_15120", "batch_size": 260, "batch_pos": 162, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The phrase 'too early to tell' and verb 'manufacture' are neutral.", "method": "llm_batch", "batch_id": "batch_2_17528", "batch_size": 260, "batch_pos": 160, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment discusses future manufacturing potential, not the virus's realised impact.", "method": "llm_batch", "batch_id": "batch_3_14580", "batch_size": 260, "batch_pos": 140, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_7416", "batch_size": 260, "batch_pos": 139, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment states uncertainty ('too early to tell') but lacks an explicit calming cue.", "method": "llm_batch", "batch_id": "batch_5_6596", "batch_size": 260, "batch_pos": 138, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_17096", "batch_size": 260, "batch_pos": 133, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation cue.", "method": "llm_batch", "batch_id": "batch_7_14640", "batch_size": 260, "batch_pos": 129, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "States uncertainty about future manufacturing capacity ('too early to tell how many doses... will be able to manufacture'), relating to future capability.", "method": "llm_batch", "batch_id": "batch_8_14580", "batch_size": 260, "batch_pos": 113, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
